Journal of Clinical Endocrinology & Metabolism, Vol 77, 1323-1328, Copyright © 1993 by Endocrine Society

ARTICLES

Human kidney as target for somatostatin: high affinity receptors in tubules and vasa recta

JC Reubi, U Horisberger, UE Studer, B Waser and JA Laissue
Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Bern, Switzerland.

Somatostatin (SRIH) receptors were identified in human kidneys by in vitro receptor autoradiography using 125I-[Tyr3]octreotide and 125I- [Leu8,D-Trp22,Tyr25]SRIH-28 as radioligands. Characterization of the binding demonstrated a single class of high affinity binding sites with a dissociation constant (Kd) of 0.5 nmol/L. Binding depended on GTP and magnesium and sodium concentrations. SRIH-14, SRIH-28, and octreotide were able to displace the radioligand in the high affinity range, whereas biologically inactive SRIH analogs or unrelated peptides were not. Microscopic localization of these receptors revealed binding over cortical and medullary areas. In the cortex, the receptors were located in the proximal tubules. No SRIH receptors were found in the glomeruli. In the medulla, the receptors were identified in high density in medullary vasa recta. A diffuse labeling of lesser density observed in the remaining medulla corresponded to collecting tubules. The receptor concentration was 32 fmol/mg protein in the renal cortex and 304 fmol/mg protein in the vasa recta. The receptors were undetectable in the rat kidney and are, thus, species dependent. SRIH receptors in the human kidney may be the molecular basis for the actions of SRIH on renal functions and may indicate a therapeutic potential for SRIH analogs in this tissue.

This article has been cited by other articles:

				S. Bhandari, N. Watson, E. Long, S. Sharpe, W. Zhong, S.-Z. Xu, and S. L. Atkin Expression of Somatostatin and Somatostatin Receptor Subtypes 1-5 in Human Normal and Diseased Kidney J. Histochem. Cytochem., August 1, 2008; 56(8): 733 - 743. [Abstract] [Full Text] [PDF]

				Y. Segev, R. Eshet, I. Rivkis, C. Hayat, L. Kachko, M. Phillip, and D. Landau Comparison between somatostatin analogues and ACE inhibitor in the NOD mouse model of diabetic kidney disease Nephrol. Dial. Transplant., December 1, 2004; 19(12): 3021 - 3028. [Abstract] [Full Text] [PDF]

				J. C. Reubi Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy Endocr. Rev., August 1, 2003; 24(4): 389 - 427. [Abstract] [Full Text] [PDF]

				D. A. Balster, M. S. O'Dorisio, M. A. Summers, and M. A. Turman Segmental expression of somatostatin receptor subtypes sst1 and sst2 in tubules and glomeruli of human kidney Am J Physiol Renal Physiol, March 1, 2001; 280(3): F457 - F465. [Abstract] [Full Text] [PDF]

				D. Kwekkeboom, E. P. Krenning, and M. de Jong Peptide Receptor Imaging and Therapy J. Nucl. Med., October 1, 2000; 41(10): 1704 - 1713. [Abstract] [Full Text] [PDF]

				M. A. Turman and C. A. Apple Human proximal tubular epithelial cells express somatostatin: regulation by growth factors and cAMP Am J Physiol Renal Physiol, June 1, 1998; 274(6): F1095 - F1101. [Abstract] [Full Text] [PDF]